Skip to main content
Fig. 2 | BMC Public Health

Fig. 2

From: Association of volatile organic compound exposure with metabolic syndrome and its components: a nationwide cross-sectional study

Fig. 2

Heatmap of Spearman correlation analysis for urinary mVOCs. Notes: *, statistical significance (P < 0.05). Abbreviations: CEMA, N-Acetyl-S-(2-carboxyethyl)-L-cysteine; 3HPMA, N-Acetyl-S-(3-hydroxypropyl)-L-cysteine; AAMA, N-Acetyl-S-(2-carbamoylethyl)-L-cysteine; CYMA, N-Acetyl-S-(2-cyanoethyl)-L-cysteine; DHBMA, N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine; MHBMA3, N-Acetyl-S-(4-hydroxy-2-butenyl)-L-cysteine; HMPMA, N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine; ATCA, 2-Aminothiazoline-4-carboxylic acid; AMCC, N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine; PGA, Phenylglyoxylic acid; MA, Mandelic acid; 2HPMA, N-Acetyl-S-(2-hydroxypropyl)-L-cysteine; SBMA, N-Acetyl-S-(benzyl)-L-cysteine; 2MHA, 2-Methylhippuric acid; 3,4-MHA, 3- and 4-Methylhippuric acid

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us